CompaniesISTO Technologies

ISTO Technologies

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

4

As Collaborator

1

Total Enrollment

308

By Phase

NA: 1PHASE2: 1PHASE3: 1

By Status

UNKNOWN: 3TERMINATED: 2
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
NCT01400607
NCT01771471
NCT01746212
NCT02400762
Hover over trial bars to see details

Recent Trials

NCT05222503Lead Sponsor
Impact of Sensor Technology in Knee OA
NAUnknown
60 participants
Started: Aug 19, 2021 · Completed: Jul 14, 2022
NCT02400762Lead Sponsor
Prospective Study of Safety and Efficacy of InQu® Bone Graft Extender in Lumbar Interbody Fusion Surgery
N/AUnknown
130 participants
Started: Oct 31, 2013 · Completed: Mar 31, 2019
NCT01746212Collaborator
Outcomes of Degenerative Disc Disease Patients Treated With an Anterior-Only Fusion Using InQu Bone Graft
N/AUnknown
60 participants
Started: Dec 31, 2012 · Completed: May 31, 2015
NCT01771471Lead Sponsor
A Study Comparing the Safety and Effectiveness of Cartilage Cell Injected Into the Lumbar Disc as Compared to a Placebo
PHASE2Terminated
44 participants
Started: Nov 30, 2012 · Completed: Sep 30, 2020
NCT01400607Lead Sponsor
Neocartilage Implant to Treat Cartilage Lesions of the Knee
PHASE3Terminated
14 participants
Started: Jul 31, 2011 · Completed: Sep 30, 2020
Funding History (5)
D
Jan 6, 2015
Filing
D
Mar 17, 2014
Filing
D
Jun 19, 2013
Filing
D
Dec 10, 2009
Filing
D
May 8, 2009
Filing
Related Companies
Arteriocyte Medical Systems To Become Isto Biologics
merged